Mass General Brigham, Inc

In its 13F for Q4 2025 (holdings as of December 31, 2025, filed January 27, 2026), Mass General Brigham, Inc reported 7 stock positions worth $809.8 million. Its top holding was iShares MSCI Acwi ETF (ACWI) at 80.6% of the portfolio, followed by Karman (KRMN, 14.1%) and Revolution Medicines (RVMD, 3.4%).

Most Recent 13F
Q2 2026
Location
SOMERVILLE, MA
CIK
0001678378
Portfolio Value
$809.8M (Q4 2025)
SEC Filing
0001214659-26-000882 ↗ filed Jan 27, 2026

Holdings Value

0$200.0M$400.0M$600.0M$800.0M$1.0B Q1 2024: $57.1M Q1 2024 Q2 2024: $20.5M Q2 2024 Q3 2024: $43.6M Q3 2024 Q4 2025: $809.8M $809.8M Q4 2025 Q1 2026: $468.9M Q1 2026 Q2 2026: $361.1M Q2 2026

Holdings 7 stocks · $809.8M

ACWI iShares MSCI Acwi ETF 80.62% 4,613,955 $652.8M —
KRMN Karman Holdings Inc. 14.11% 1,562,054 $114.3M —
RVMD Revolution Medicines Inc. 3.38% 344,091 $27.4M —
MAZE Maze Therapeutics Inc. 1.23% 239,994 $9.9M —
TNGX Tango Therapeutics Inc. 0.39% 354,192 $3.1M —
MDLN Medline Inc. Class A 0.14% 26,294 $1.1M —
RBRK Rubrik Inc. Class A 0.13% 14,000 $1.1M —

Portfolio Sells Q4 2025

No earlier filing to compare with.

Portfolio Buys Q4 2025

No earlier filing to compare with.

All Filings

QuarterPositions13F Reported ValueTop Holdings
Q2 2026 6$361.1MACWI, KRMN, RVMD, TNGX, MAZE
Q1 2026 6$468.9MACWI, KRMN, RVMD, TNGX, MAZE
Q4 2025 7$809.8MACWI, KRMN, RVMD, MAZE, TNGX
Q3 2024 5$43.6MIOT, RVMD, PLRX, TNGX, FULC
Q2 2024 4$20.5MRVMD, PLRX, TNGX, FULC
Q1 2024 5$57.1MCOIN, RVMD, PLRX, TNGX, FULC